Clin2
NCT06734260Possibly a fitRecruiting

Optimizing a two-drug therapy for H. pylori infection

Helicobacter Pylori Eradication Rate

Part of Digestive system, Infections clinical trials.

This trial tests a two-drug combination (keverprazan and amoxicillin) to see if it works better for treating H. pylori, a bacteria that can cause stomach problems. It is for people who have had H. pylori before and need treatment again.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
477 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have tested positive for H. pylori and need treatment, and this is your first time treatment has failed.
  • You can understand the study and agree to follow all visits and rules.
  • You are willing to use effective birth control during the study (if applicable).
  • You have not used certain stomach acid medicines or antibiotics in the past 2 to 4 weeks, depending on the type.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07122024Recruiting· Phase 4
Testing a dual therapy for H. pylori treatment

This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.

Hangzhou, Zhejiang
NCT07750938Not yet recruiting· Phase 4
Optimized treatment for H. pylori infection with stronger acid control

This study tests a new combination of medicines to treat H. pylori, a common stomach infection that can cause ulcers. The goal is to see if a stronger acid-reducing approach helps the treatment work better.

NCT06760065Not yet recruiting· Phase 3
Comparing two treatments for H. pylori after failed first therapy

This trial tests a new dual therapy (Keverprazan Hydrochloride plus amoxicillin) against a standard quadruple therapy guided by antibiotic sensitivity. It is for people whose H. pylori infection has not been cured by at least one prior treatment.

NCT06777732Not yet recruiting· Early Phase 1
Keverprazan for H. pylori infection: a new treatment option

This trial tests a new medication called Keverprazan to see if it can safely and effectively clear an H. pylori infection in the stomach. It is for people who have not yet been treated for this infection.

NCT06168214Recruiting· Phase 4
Comparing treatments for H. pylori infection

This study compares several different 2-week treatment plans to see which works best for wiping out H. pylori, a bacteria that can cause stomach ulcers and other digestive problems. If you have H. pylori, you may be able to join and receive one of the treatments.

Xi'an, Shaanxi
NCT07624422Not yet recruiting· Phase 4
Two antibiotic combinations for H. pylori stomach infection

This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.

Damascus

Hear when a new Helicobacter Pylori Eradication Rate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.